| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.68▼ | 1.69▼ | 1.69▼ | 1.73▼ | 1.89▼ |
| MA10 | 1.70▼ | 1.73▼ | 1.73▼ | 1.78▼ | 2.04▼ |
| MA20 | 1.75▼ | 1.72▼ | 1.72▼ | 1.90▼ | 2.52▼ |
| MA50 | 1.73▼ | 1.76▼ | 1.79▼ | 2.06▼ | 2.16▼ |
| MA100 | 1.81▼ | 1.87▼ | 1.92▼ | 2.50▼ | 2.42▼ |
| MA200 | 1.94▼ | 1.99▼ | 2.02▼ | 2.14▼ | 2.53▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.011▼ | -0.006▼ | -0.002▼ | -0.007▼ | -0.134▼ |
| RSI | 40.768▼ | 42.293▼ | 42.809▼ | 36.314▼ | 38.973▼ |
| STOCH | 26.689 | 16.303▼ | 34.365 | 31.487 | 7.801▼ |
| WILL %R | -72.414 | -77.143▼ | -77.143▼ | -85.000▼ | -97.232▼ |
| CCI | -93.559 | -111.481▼ | -75.084 | -89.057 | -87.507 |
|
Thursday, October 30, 2025 05:20 AM
Celularity (CELU) announced a strategic partnership with DefEYE, a newly established ophthalmic product and technology company. Celularity has ...
|
|
Thursday, October 30, 2025 05:10 AM
DefEYE’s leadership includes key personnel from the original Verséa Ophthalmics team, ensuring continuity of expertise and relationships in the rapidly evolving eye care market. Celularity has the ...
|
|
Tuesday, October 14, 2025 01:45 AM
As a qualified stem cell therapy under Florida statute (§ 458.3245), effective July 1, 2025 authorizing use in wound care, orthopedics, and pain management, PDA-002 may offer licensed Florida ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/11/25 | 1.695 | 1.695 | 1.67 | 1.675 | 49,180 |
| 11/11/25 | 1.746 | 1.79 | 1.60 | 1.72 | 79,623 |
| 10/11/25 | 1.751 | 1.83 | 1.73 | 1.77 | 65,859 |
| 07/11/25 | 1.716 | 1.7859 | 1.66 | 1.78 | 64,175 |
| 06/11/25 | 1.86 | 1.8809 | 1.6539 | 1.69 | 72,880 |
| 05/11/25 | 1.72 | 1.85 | 1.64 | 1.84 | 35,292 |
| 04/11/25 | 1.73 | 1.74 | 1.62 | 1.72 | 67,161 |
| 03/11/25 | 1.90 | 1.90 | 1.70 | 1.72 | 123,036 |
| 31/10/25 | 1.92 | 1.96 | 1.88 | 1.95 | 16,443 |
| 30/10/25 | 1.99 | 1.99 | 1.88 | 1.89 | 73,825 |
|
|
||||
|
|
||||
|
|